These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15683712)

  • 1. Oxidant stress but not thromboxane decreases with epoprostenol therapy.
    Robbins IM; Morrow JD; Christman BW
    Free Radic Biol Med; 2005 Mar; 38(5):568-74. PubMed ID: 15683712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.
    Oikawa M; Kagaya Y; Otani H; Sakuma M; Demachi J; Suzuki J; Takahashi T; Nawata J; Ido T; Watanabe J; Shirato K
    J Am Coll Cardiol; 2005 Jun; 45(11):1849-55. PubMed ID: 15936618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
    Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
    Lung; 2001; 179(4):233-43. PubMed ID: 11891614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
    Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
    J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
    Kom GD; Schwedhelm E; Nielsen P; Böger RH
    Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK; Bass NM; De Marco T; Merriman RB
    Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.
    Ferrante E; Vazzana N; Santilli F; Di Cicco M; Lauriti C; Di Battista L; Ciabattoni G; Di Matteo L; Davì G
    Free Radic Biol Med; 2010 Sep; 49(5):857-64. PubMed ID: 20541603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers.
    McAdam BF; Byrne D; Morrow JD; Oates JA
    Circulation; 2005 Aug; 112(7):1024-9. PubMed ID: 16087791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in urinary dinor dihydro F(2)-isoprostane metabolite concentrations, a marker of oxidative stress, during and following asthma exacerbations.
    Wu P; Roberts LJ; Shintani AK; Sheller JR; Minton PA; Higgins SB; Hartert TV
    Free Radic Res; 2007 Sep; 41(9):956-62. PubMed ID: 17729112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
    Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
    Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
    Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis.
    Cracowski JL; Kom GD; Salvat-Melis M; Renversez JC; McCord G; Boignard A; Carpentier PH; Schwedhelm E
    Free Radic Biol Med; 2006 May; 40(10):1732-7. PubMed ID: 16678012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2alpha in a 27 year follow-up study of Swedish men.
    Helmersson J; Arnlöv J; Vessby B; Larsson A; Alfthan G; Basu S
    Free Radic Res; 2005 Jul; 39(7):763-70. PubMed ID: 16036356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoprostenol therapy for primary pulmonary hypertension.
    Cheever KH; Kitzes B; Genthner D
    Crit Care Nurse; 1999 Aug; 19(4):20-7. PubMed ID: 10614244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
    Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
    Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoprostenol therapy decreases elevated circulating levels of monocyte chemoattractant protein-1 in patients with primary pulmonary hypertension.
    Katsushi H; Kazufumi N; Hideki F; Katsumasa M; Hiroshi M; Kengo K; Hiroshi D; Nobuyoshi S; Tetsuro E; Hiromi M; Tohru O
    Circ J; 2004 Mar; 68(3):227-31. PubMed ID: 14993777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).
    Dworski R; Roberts LJ; Murray JJ; Morrow JD; Hartert TV; Sheller JR
    Clin Exp Allergy; 2001 Mar; 31(3):387-90. PubMed ID: 11260149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia.
    Yamada M; Omata K; Abe F; Ito S; Abe K
    Immunopharmacology; 1999 Oct; 44(1-2):193-8. PubMed ID: 10604544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated.
    Camphausen K; Ménard C; Sproull M; Goley E; Basu S; Coleman CN
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1536-9. PubMed ID: 15050334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.